Daiwa Securities Group Inc. Has $3.78 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Daiwa Securities Group Inc. raised its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 52.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,274 shares of the company's stock after acquiring an additional 8,034 shares during the period. Daiwa Securities Group Inc.'s holdings in Clorox were worth $3,780,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Advisors Asset Management Inc. boosted its holdings in Clorox by 43.4% during the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock valued at $4,865,000 after acquiring an additional 9,037 shares during the period. Natixis Advisors LLC raised its position in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock valued at $10,341,000 after buying an additional 4,839 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock valued at $117,932,000 after buying an additional 13,038 shares during the last quarter. Public Employees Retirement System of Ohio raised its position in shares of Clorox by 26.3% during the third quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock valued at $9,736,000 after buying an additional 12,428 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC acquired a new position in shares of Clorox during the fourth quarter valued at about $204,000. 78.53% of the stock is currently owned by institutional investors.

Remove Ads

Clorox Price Performance

Clorox stock traded up $1.38 on Monday, reaching $148.54. The company's stock had a trading volume of 958,543 shares, compared to its average volume of 1,216,261. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market cap of $18.30 billion, a price-to-earnings ratio of 40.58, a PEG ratio of 2.62 and a beta of 0.45. The business's fifty day moving average price is $154.20 and its 200 day moving average price is $160.23. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company earned $2.16 EPS. Equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on CLX shares. DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Evercore ISI boosted their price objective on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Wells Fargo & Company boosted their price objective on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Finally, Barclays boosted their price objective on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research report on Wednesday, February 5th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.